– CANADA, Moncton – Organigram Holdings Inc. (TSX: OGI / NASDAQ: OGI) today announced the appointment of Karina Gehring to its Board of Directors effective on January 18, 2024.
About Karina Gehring
Karina Gehring is one of two directors along with Simon Ashton, designated by BT DE Investments Inc., a wholly-owned subsidiary of British American Tobacco plc, as nominees to the Board. Bringing over 25 years of experience in marketing and trade at BAT, Karina Gehring is a seasoned executive proficient in commercial delivery, brand management, strategy, consumer insights, and key account management. Leading diverse teams, she has played a pivotal role in transformative initiatives across Europe and Canada. Mrs. Gehring has successfully executed full portfolio brand repositioning, deepened BAT’s consumer understanding to foster connections beyond surface insights, and introduced innovative key account management programs.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a company whose wholly owned subsidiaries include Organigram Inc. a licensed producer of cannabis, cannabis-derived products, and cannabis-infused edibles in Canada.
Organigram is focused on producing high-quality cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis, and Trailblazer. Organigram operates facilities in Moncton, New Brunswick, and Lac-Supérieur, Quebec, with a dedicated edible manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).
For more information: https://www.organigram.ca
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
